The recent meta-analysis by Wang et al. pooled the data of 8 case-control studies and indicated the CYP1A1 Ile462Val polymorphism might be a risk factor for cervical cancer (Wang et al., 2015). The gene discussed is CYP1A1; the disease is cervical carcinoma.